Common questions about Competact (FAQ)
Q: How quickly should I expect Competact to start working?
A: Official documents state that the adequacy of your blood sugar control should be reviewed by your doctor after three to six months of starting therapy. While individual responses may vary, official follow-up periods are established to confirm the sustained response to the treatment.
Q: Is it safe to drink alcohol while taking Competact?
A: Regulatory documents state that excessive alcohol intake must be avoided while taking this medication. The combination of metformin (one of the components) and excessive alcohol can significantly increase the risk of a rare but serious metabolic complication called lactic acidosis. Guidance on social or moderate alcohol consumption requires discussion with a healthcare provider.
Q: How does Competact compare to taking pioglitazone and metformin separately?
A: Regulatory studies have shown that the fixed-dose combination tablet is bioequivalent, meaning it delivers the active ingredients to the body in the same way as taking the two individual medicines separately. The fixed-dose combination structure is intended to offer a simplified regimen when both active substances are medically appropriate.
Q: Does Competact have a 'black box warning' in the US?
A: The US Food and Drug Administration (FDA) requires a Boxed Warning—often called a 'black box warning'—for this product. This prominent warning highlights the risk of Congestive Heart Failure and Lactic Acidosis associated with the components of the medicine. These serious safety concerns are highlighted in the labeling, providing context for discussion with a healthcare provider.
Q: Is Competact a type of insulin?
A: No, Competact is not a type of insulin. It belongs to a class of medicines known as Oral Antihyperglycemic Agents. It is a combination product that works by using two active ingredients to help the body use the insulin it already produces more effectively and by decreasing the amount of glucose the liver releases into the blood.
Q: If I miss a dose of Competact, what is the generally recommended action?
A: Official patient information generally advises that if a dose is missed, you should not double the dose the following day. Instead, you should simply take your next scheduled dose as usual. Patients are generally advised to follow the directions provided by their healthcare professional regarding missed doses.
Q: What happens if I stop taking Competact suddenly?
A: Official patient information advises against stopping the medicine without first discussing it with a healthcare provider. Stopping treatment may lead to a loss of blood sugar control and subsequent high blood sugar (hyperglycemia).
Q: Are there any major diet restrictions while taking Competact?
A: Official information emphasizes the need to avoid excessive alcohol intake due to safety risks. Beyond this restriction, the medicine is simply recommended to be taken with or just after food to help minimize potential stomach side effects. It is indicated for use alongside a prescribed diet and exercise plan.
Q: Does Competact interact with over-the-counter pain relievers like ibuprofen?
A: The official product information lists that certain drug classes, including some that contain non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen, can potentially increase the risk of lactic acidosis by affecting kidney function. Your healthcare provider should be informed of all over-the-counter medications and supplements you take.
Q: What is the half-life of Competact in the body?
A: The components of Competact have different half-lives. The pioglitazone component has an approximate average plasma half-life of 3 to 7 hours, with its active metabolites lasting longer. The metformin component has an approximate elimination half-life of 6.2 hours in plasma. The half-life describes the time it takes for half of the substance to be eliminated from the body.
Q: Can Competact cause low blood sugar (hypoglycemia)?
A: The metformin component is generally described as having a low risk of causing low blood sugar (hypoglycemia) when used alone. However, official documents note that the risk of low blood sugar is increased when Competact is used in combination with other anti-diabetic medications, such as insulin or sulfonylureas.
Q: Is it common for people to feel nauseous when starting Competact?
A: Yes, nausea is listed as a very common adverse reaction, which is mostly associated with the metformin component. Official documents indicate that these types of gastrointestinal side effects occur most frequently during the initiation of therapy and official information indicates these effects typically diminish with continued use.
Q: Can Competact cause joint pain or muscle stiffness?
A: Official documents list Arthralgia (joint pain) as a common adverse reaction for the pioglitazone component of the medicine. Additionally, a common adverse reaction reported is bone fracture, particularly in female patients.
Q: Does Competact have any known interactions with herbal supplements?
A: Regulatory documents primarily detail interactions with prescription medicines. While some herbal supplements, such as those that impact blood glucose, may require caution, specific interactions are not comprehensively listed in core labels. It is always recommended to disclose all herbal supplements to your healthcare provider.
Q: Do studies suggest Competact affects cholesterol levels?
A: Clinical trials reported that the pioglitazone component generally resulted in mean decreases in serum triglycerides and mean increases in HDL ('good') cholesterol. These studies did not report a consistent mean change in LDL and total cholesterol.
Q: What is the maximum duration people typically take Competact?
A: Official documents do not set a maximum duration of use but stress the importance of periodic treatment review by a healthcare provider to confirm sustained benefit. It is noted that the risk of bladder cancer may be increased with long-term exposure, which is defined as use for more than one year.
Q: What is the typical starting dosage strength for Competact?
A: Official prescribing information describes the usual daily dose as a combination providing 30 mg of pioglitazone and 1700 mg of metformin, typically taken as one 15 mg/850 mg tablet twice daily. Official guidance indicates that a healthcare provider assesses the appropriate starting dose based on an individual's prior treatment and needs.
Q: Is Competact generally more effective than lifestyle changes alone?
A: The medicine is officially indicated for use as an adjunct to diet and exercise for blood sugar management. Clinical studies evaluated its effect as an addition to existing therapies, rather than as a comparison to lifestyle changes as a sole treatment option.
Q: Can Competact affect eye health or vision?
A: Official documents list visual disturbance as a common adverse reaction. This is often reported early in treatment and is generally thought to be related to temporary changes in the lens of the eye caused by fluctuations in blood sugar levels.
Q: Does Competact cause fatigue or tiredness?
A: Fatigue or tiredness is not listed as a routine common side effect in official documents. However, it is noted as a potential symptom of several serious conditions related to the drug, such as heart failure or lactic acidosis.
Q: Can Competact be crushed or split?
A: Official patient instructions state that the tablets must be swallowed whole with water. Crushing, breaking, or chewing them is advised against to ensure the proper administration of the medicine.
Q: Are there any restrictions on driving or operating machinery while on Competact?
A: The medicine is not expected to impair the ability to drive or use machines. However, official information advises caution if a patient experiences side effects like abnormal vision while taking the medication.
